Pulmonary adverse events associated with GLP-1 receptor agonists: a systematic review of respiratory safety signals.

Cardiovasc Diabetol Endocrinol Rep · 2026 · PMC13281493 · PMID 42316363

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Zhang 2025 (FAERS; n = 20,350 tirzepatide reports) identified a reporting signal for dyspnoea with tirzepatide (ROR 1.18, 95% CI 0.95–1.47), which did not reach statistical significance [ 2 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.